The benefit of GLP-1RA in different age groups in the cardiovascular outcome trials.
Diabetes Res Clin Pract
; 177: 108878, 2021 Jul.
Article
em En
| MEDLINE
| ID: mdl-34058302
ABSTRACT
There may be hesitancy in prescribing GLP-1RA in older adults. On pooling results from the CVOTs comparing GLP-1RA to placebo, there was a significantly lower incidence of MACE favoring GLP-1RA in both younger and older adults. GLP-1RA should be considered in high risk patients regardless of age.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doenças Cardiovasculares
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article